FDA Inspection 1022643 — Ascensia Diabetes Care US, Inc.
The FDA completed an inspection of Ascensia Diabetes Care US, Inc. on August 7, 2017 in Valhalla, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 7, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Valhalla, NY (United States)